Loading candles…
Vanta Bioscience Ltd, incorporated in 2016 and headquartered in Gummidipoondi, Tamil Nadu, India, operates as a full-service preclinical contract research organization. It specializes in toxicology evaluation services that include safety assessment and regulatory compliance support, primarily serving clients in the pharmaceutical, biotechnology, and chemical industries. The company offers services related to drugs, medical devices, agrochemicals, and food additives. It maintains a research facility in its headquarters location to support its operations. Vanta Bioscience does not have listed subsidiaries or ventures and is not publicly listed on any exchange.
This page is a live market overview for Vanta Bioscience Limited (VANTABIO) on the BSE. As a listed security, Vanta Bioscience Limited is tracked in the Equities segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for VANTABIO before placing trades on tick2trade.
As of the latest feed, VANTABIO last traded at ₹20.39 on BSE, down ₹0.01 (0.05%) from the previous close of ₹20.4. Today's session range is ₹20.39 – ₹20.39, against a 52-week band of ₹20.39 – ₹20.39. Traded volume today stands at 750 shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for VANTABIO in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether VANTABIO is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for Vanta Bioscience Limited before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in VANTABIO. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated VANTABIO option chain page linked from this overview.
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.
The accounts listed under Official handles are the only social media accounts operated by Tick2trade / Besseggen InfoTech LLP. We do not provide trading tips, stock recommendations or assured-return schemes, and we never ask for your login details, OTPs or payments over social media or messaging apps. Any other account, group or channel using our name is not associated with us; please report it to support@tick2trade.com.